Albireo Stock Future Price Prediction

ALBO
 Stock
  

USD 23.78  0.84  3.66%   

Albireo Pharma stock price prediction is an act of determining the future value of Albireo Pharma shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Albireo Pharma's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Albireo Pharma and does not consider all of the tangible or intangible factors available from Albireo Pharma's fundamental data. We analyze noise-free headlines and recent hype associated with Albireo Pharma, which may create opportunities for some arbitrage if properly timed.
Please continue to Albireo Pharma Basic Forecasting Models to cross-verify your projections.
  
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Albireo Pharma based on different types of headlines from major news networks to social media. The Albireo stock price prediction module provides an analysis of price elasticity to changes in media outlook on Albireo Pharma over a specific investment horizon.
EPS Estimate Next Quarter
(1.87) 
EPS Estimate Current Year
(7.93) 
EPS Estimate Next Year
(6.58) 
Wall Street Target Price
58.67
EPS Estimate Current Quarter
(1.06) 
Quarterly Revenue Growth YOY
1.68
Using Albireo Pharma hype-based prediction, you can estimate the value of Albireo Pharma from the perspective of Albireo Pharma response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Albireo Pharma using Albireo Pharma's stock options and short interest. It helps to benchmark the overall future attitude of investors towards Albireo using crowd psychology based on the activity and movement of Albireo Pharma's stock price.
Albireo Pharma Price to Sales Ratio is quite stable at the moment as compared to the past year. The company's current value of Price to Sales Ratio is estimated at 11.32. Sales per Share is expected to rise to 2.43 this year, although the value of PPandE Turnover will most likely fall to 61.97.

Albireo Pharma Short Interest

A significant increase or decrease in Albireo Pharma's short interest from the previous month could be a good indicator of investor sentiment towards Albireo. Short interest can provide insight into the potential direction of Albireo Pharma stock and how bullish or bearish investors feel about the market overall. An investor who is long Albireo Pharma may also wish to track short interest. As short interest increases, investors should be becoming more worried about Albireo Pharma and may potentially protect profits, hedge Albireo Pharma with its derivative instruments, or be ready for some potential downside.
200 Day MA
24.09
Short Percent
0.0685
Short Ratio
5.09
Shares Short Prior Month
1.7 M
50 Day MA
21.08
Shares Short
1.1 M

Albireo Pharma Hype to Price Pattern

Investor biases related to Albireo Pharma's public news can be used to forecast risks associated with investment in Albireo. The trend in average sentiment can be used to explain how an investor holding Albireo can time the market purely based on public headlines and social activities around Albireo Pharma. Please note that most equiteis that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Albireo Pharma's market sentiment to its price can help taders to make decisions based on the overall investors consensus about Albireo Pharma.

Albireo Pharma Implied Volatility

    
  63.13  
Albireo Pharma's implied volatility exposes the market's sentiment of Albireo Pharma stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Albireo Pharma's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Albireo Pharma stock will not fluctuate a lot when Albireo Pharma's options are near their expiration.
This module is based on analyzing investor sentiment around taking a position in Albireo Pharma. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Albireo Pharma to buy its stock at a price that has no basis in reality. In that case, they are not buying Albireo because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Albireo Pharma after-hype prediction price

    
  USD 22.48  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Albireo Pharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Albireo Pharma in the context of predictive analytics.
Intrinsic
Valuation
LowReal ValueHigh
21.4036.2941.06
Details
5 Analysts
Consensus
LowTarget PriceHigh
67.0075.8084.00
Details
Earnings
Estimates (4)
LowProjected EPSHigh
-6.72-5.57-3.13
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Albireo Pharma. Your research has to be compared to or analyzed against Albireo Pharma's peers to derive any actionable benefits. When done correctly, Albireo Pharma's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Albireo Pharma.

Albireo Pharma After-Hype Price Prediction Density Analysis

As far as predicting the price of Albireo Pharma at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Albireo Pharma or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Albireo Pharma, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Albireo Pharma Estimiated After-Hype Price Volatility

In the context of predicting Albireo Pharma's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Albireo Pharma's historical news coverage. Albireo Pharma's after-hype downside and upside margins for the prediction period are 17.71 and 27.25, respectively. We have considered Albireo Pharma's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value 23.78
22.48
After-hype Price
27.25
Upside
Albireo Pharma is not too volatile asset. Analysis and calculation of next after-hype price of Albireo Pharma is based on 3 months time horizon.

Albireo Pharma Stock Price Prediction Analysis

Have you ever been surprised when a price of a company such as Albireo Pharma is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Albireo Pharma backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Albireo Pharma, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
 0.70  4.77   1.30   0.59  6 Events / Month1 Events / MonthIn about 6 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
23.7822.485.47 
256.45  

Albireo Pharma Hype Timeline

Albireo Pharma is presently traded for 23.78. The entity has historical hype elasticity of -1.3 and average elasticity to hype of competition of 0.59. Albireo is forecasted to decline in value after the next headline with the price expected to drop to 22.48. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next newsis expected to be -5.47% whereas the daily expected return is presently at 0.7%. The volatility of related hype on Albireo Pharma is about 570.12% with expected price after next announcement by competition of 24.37. About 97.0% of the company shares are held by institutions such as insurance companies. The book value of Albireo Pharma was presently reported as 4.84. The company recorded a loss per share of 1.7. Albireo Pharma last dividend was issued on the 4th of November 2016. The entity had 1:30 split on the 4th of November 2016. Given the investment horizon of 90 days the next forecasted press release will be in about 6 days.
Please continue to Albireo Pharma Basic Forecasting Models to cross-verify your projections.

Albireo Pharma Related Hype Analysis

Having access to credible news sources related to Albireo Pharma's direct competition is more important than ever and may enhance your ability to predict Albireo Pharma's future price movements. Getting to know how Albireo Pharma rivals react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Albireo Pharma may potentially react to the hype associated with one of its peers.

Albireo Pharma Additional Predictive Modules

Most predictive techniques to examine Albireo price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Albireo using various technical indicators. When you analyze Albireo charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Albireo Pharma Predictive Indicators

The successful prediction of Albireo Pharma stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Albireo Pharma, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Albireo Pharma based on analysis of Albireo Pharma hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Albireo Pharma's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Albireo Pharma's related companies.
 2021 2022 (projected)
Receivables Turnover6.36.79
PPandE Turnover70.8261.97

Story Coverage note for Albireo Pharma

The number of cover stories for Albireo Pharma depends on current market conditions and Albireo Pharma's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Albireo Pharma is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Albireo Pharma's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Albireo Pharma Short Properties

Albireo Pharma's future price predictability will typically decrease when Albireo Pharma's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Albireo Pharma often depends not only on the future outlook of the potential Albireo Pharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Albireo Pharma's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding19220846.00
Cash And Short Term Investments248107000.00
Please continue to Albireo Pharma Basic Forecasting Models to cross-verify your projections. Note that the Albireo Pharma information on this page should be used as a complementary analysis to other Albireo Pharma's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Complementary Tools for Albireo Stock analysis

When running Albireo Pharma price analysis, check to measure Albireo Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Albireo Pharma is operating at the current time. Most of Albireo Pharma's value examination focuses on studying past and present price action to predict the probability of Albireo Pharma's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Albireo Pharma's price. Additionally, you may evaluate how the addition of Albireo Pharma to your portfolios can decrease your overall portfolio volatility.
Fund Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Go
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Go
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
CEO Directory
Screen CEOs from public companies around the world
Go
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Go
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Go
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Go
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Go
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Go
Is Albireo Pharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Albireo Pharma. If investors know Albireo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Albireo Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
492.3 M
Quarterly Revenue Growth YOY
1.68
Return On Assets
(0.25) 
Return On Equity
(0.93) 
The market value of Albireo Pharma is measured differently than its book value, which is the value of Albireo that is recorded on the company's balance sheet. Investors also form their own opinion of Albireo Pharma's value that differs from its market value or its book value, called intrinsic value, which is Albireo Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Albireo Pharma's market value can be influenced by many factors that don't directly affect Albireo Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Albireo Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine Albireo Pharma value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Albireo Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.